000 | 01755nam a2200169Ia 4500 | ||
---|---|---|---|
008 | 140223b2004 xxu||||| |||| 00| 0 eng d | ||
020 |
_a9781574911022 _c0.00 |
||
082 |
_a615 _bTWE |
||
245 | _aTwenty - First Century Pharmaceutical Development | ||
260 |
_aColorado _bInterpharm Press _c2004 |
||
300 | _a388p | ||
500 | _aOrganized according to the functional disciplines involved in the development of drugs, Twenty-First Century Pharmaceutical Development provides an overview of the key aspects of the current drug development process and possibilities for the future. The book covers financial strategies for small drug developers, managing basic research, protecting intellectual property, marketing, regulatory issues, preclinical toxicology studies, drug product formulation development, manufacturing, developing a clinical strategy, the role of statistics, project management, outsourcing, diagnostics, medical devices, and more. supportive endpoints, reimbursement planning, clinical proposal, preformulation activities, healthcare buyers, finished device manufacturer, preliminary market analysis, liquid oral preparations, preclinical toxicology studies, discovery continuum, formulation scientist, tablet core, dosage form development, solid oral dosage forms, dry granulation, quality system audits, clinical supplies, protein therapeutics, pharmaceutical dosage forms, pharmaceutical development, outsourcing providers, drug developers, toxic stimuli, longitude problem, diagnostic products | ||
600 |
_aPharmaceutical Development _918082 |
||
700 |
_aBlaisdell, Peter _eEditor _918620 |
||
942 |
_2ddc _cLB _k615 _mTWE |
||
995 |
_aPharmacy Reference _eP0005785 _j615 _yP0005785 |
||
999 |
_c16363 _d16363 |